Thomas H. Adams's most recent trade in Hepion Pharmaceuticals Inc was a trade of 200,000 Stock Options done . Disclosure was reported to the exchange on May 18, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Hepion Pharmaceuticals Inc | Thomas H. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 200,000 | 291,050 | - | - | Stock Options | |
Hepion Pharmaceuticals Inc | Thomas H. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2020 | 30,000 | 91,050 | - | - | Stock Options |